DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on May 31, 2006; DOI: 10.1124/dmd.106.009761


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.009761v1
34/9/1462    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y.
Right arrow Articles by Zeng, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.
Right arrow Articles by Zeng, S.


Received for publication February 14, 2006.
Revised May 17, 2006.
Accepted for publication May 30, 2006.

Genetic Variants of Human UGT1A3: Functional Characterization and Frequency Distribution in a Chinese Han Population

Yakun Chen 1, Shuqing Chen 1, Xin Li 1, Xiewei Wang 1, Su Zeng 1*

1 Zhejiang University

* Address correspondence to: E-mail: zengsu060{at}sohu.com

Abstract

UDP-glucuronosyltransferase1A3 (UGT1A3) contributes to glucuronidations of many important endogenous compounds and xenobiotics, including some flavonoids. Recently, a total of six single nucleotide polymorphisms (SNPs) have been identified in the human UGT1A3 gene. Among them, four SNPs (A17G, Q6R; T31C, W11R; C133T, R45W and T140C, V47A) cause amino acid substitutions. Variants caused by these SNPs showed an activity change in estrone metabolism, while their activities towards other substrates were not examined. In the present study, three common flavonoids, quercetin, luteolin and kaempferol, were used as substrates for glucuronidations by wild-type and variant UGT1A3s. Our results demonstrated that the activities of three variants, UGT1A3.2, UGT1A3.3 and UGT1A3.5, were remarkably lower than that of UGT1A3.1. In contrast, UGT1A3.4 exhibited an approximately four times increase in the glucuronidation efficiency and a clear preference to quercetin 7- and 3- hydroxyl groups. The frequency distributions of UGT1A3 alleles and SNPs in UGT1A3 in a Chinese Han population were statistically different from the reported value in German-Caucasian (*p < 0.05). UGT1A3 variants have an altered glucuronidation activity towards quercetin, luteolin and kaempferol, and may alter human susceptibility to flavonoids exposure.


Key words: genetic polymorphism, phase II drug metabolism, site-directed mutagenesis, UDP glucuronyltransferases


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
T. Kubota, B. C. Lewis, D. J. Elliot, P. I. Mackenzie, and J. O. Miners
Critical Roles of Residues 36 and 40 in the Phenol and Tertiary Amine Aglycone Substrate Selectivities of UDP-Glucuronosyltransferases 1A3 and 1A4
Mol. Pharmacol., October 1, 2007; 72(4): 1054 - 1062.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.